Hba1c 8.8, FBS 181, PLBS 280, obese female. How effective is sitaglipt

Hba1c 8.8, FBS 181, PLBS 280, obese female. How effective is sitagliptin 100mg + glimipride 2mg morning dose after breakfast

Hba1c 8.8, FBS 181, PLBS 280, obese female. How effective is sitagliptin 100mg + glimipride 2mg morning dose after breakfast and metformin 1gram night dose after dinner

Reading File

Finding Sources

Your sugars are clearly above target (HbA1c 8.8%, fasting 181, post-meal 280), so this is uncontrolled type 2 diabetes and treatment intensification is usually needed.

How effective is your current combination likely to be?

Sitagliptin 100 mg: moderate effect, typically lowers HbA1c by about 0.5 to 0.8%
Glimepiride 2 mg: stronger glucose lowering, often about 1 to 1.5% HbA1c reduction, but risk of hypoglycemia and weight gain
Metformin 1 g/day: usually about 1 to 1.5% reduction depending on dose tolerance; weight-neutral to mild weight loss

So in principle, this 3-drug combination can be effective, and many people can improve substantially.
But with obesity and HbA1c 8.8, this regimen may still be suboptimal if:

meals are high carbohydrate
adherence/timing is inconsistent
metformin dose is not fully optimized
insulin resistance is marked

Important practical points for your exact regimen:

Dose timing

Metformin is usually most effective as divided dose (for example morning + evening) or XR once daily with dinner, not just a single night dose in everyone.
Glimepiride is usually taken with breakfast or first main meal (as you are doing), but glucose logs decide whether dose change is needed.

Obesity context

Sulfonylureas (glimepiride) can increase weight.
In overweight/obese patients, many guidelines prefer adding drugs with weight loss benefit (GLP-1 RA or SGLT2 inhibitor) if feasible.

Safety

Watch for hypoglycemia symptoms with glimepiride (sweating, tremor, hunger, confusion), especially if meals are delayed.
Kidney function matters for metformin and sitagliptin dose selection.

What to expect

Recheck after about 3 months (or earlier with home glucose trends).
If fasting and post-meal sugars remain high, doctors typically adjust dose or switch/add agents rather than continue unchanged.

From textbook evidence:

A large comparative effectiveness trial cited in Goodman and Gilman and Harrison notes that, when added to metformin, liraglutide or basal insulin gave slightly better glycemic control than glimepiride or sitagliptin. This supports that your current combo can work, but may not be the strongest option for HbA1c 8.8 with obesity. - Goodman and Gilman’s The Pharmacological Basis of Therapeutics, p. 3074-3090; Harrison’s Principles of Internal Medicine 22E, p. 1195-1196

Please discuss medication changes only with your clinician. If you want, I can help you with a structured next-visit plan (what labs to carry, what glucose readings to track, and what medication options to ask about).

Hba1c 8.8, FBS 181, PLBS 280, obese female. How effective is sitagliptin 100mg + glimipride 2mg morning dose after breakfast and metformin 1gram night dose after dinner

With HbA1c 8.8%, fasting 181, and post-meal 280, this regimen is reasonable but often not sufficient by itself in an obese patient unless lifestyle changes are strong.

Expected effectiveness (typical HbA1c drop ranges):

Metformin: about 1.0 to 1.5%
Glimepiride: about 1.0 to 1.5%
Sitagliptin: about 0.5 to 0.8%

So combined, many patients improve meaningfully, but real-world response varies. If adherence is good and sugars are still high after about 3 months, treatment usually needs intensification or adjustment.

Key points for your exact plan:

Glimepiride 2 mg after breakfast can lower sugars but may cause hypoglycemia and weight gain.
Sitagliptin is weight-neutral, low hypoglycemia risk.
Metformin 1 g only at night may be submaximal in some patients; many do better with split dosing or XR titration if tolerated.
In obesity, options with weight-loss benefit (GLP-1 RA, SGLT2 inhibitor) are often favored over escalating sulfonylurea.

Targets (common):

HbA1c <7% (individualized)
Fasting ~80 to 130 mg/dL
2-hour post-meal <180 mg/dL

Your current values are above these targets, so discuss early review with your doctor rather than waiting too long.

From textbook evidence:

Comparative effectiveness data cited in major internal medicine/pharmacology texts show that when added to metformin, liraglutide or basal insulin provided slightly better glycemic control than glimepiride or sitagliptin in a large trial. This means your combination can work, but may not be the strongest strategy if control remains poor. - Goodman and Gilman’s The Pharmacological Basis of Therapeutics, p. 3074-3090; Harrison’s Principles of Internal Medicine 22E, p. 1195-1196

If you want, I can help you build a 12-week glucose/lab tracking sheet to judge objectively whether this regimen is working.

Sitagliptin 50mg effective time and half life

Sitagliptin pharmacokinetics (including 50 mg dose) are generally:

Time to peak level (Tmax): about 1 to 4 hours after oral dose
Plasma half-life: about 12 hours (roughly 8 to 14 hours reported)
Duration of DPP-4 inhibition / glucose-lowering effect: about 24 hours, which is why it is usually dosed once daily

Clinical “effective time”:

It starts working the same day, but visible glucose trend improvement is usually seen over several days to 1 to 2 weeks.
HbA1c benefit is assessed after about 8 to 12 weeks.

Dose note:

50 mg is commonly used when kidney function is reduced (moderate renal impairment); standard dose is often 100 mg daily when renal function is normal.

This is a shared conversation. Sign in to Orris to start your own chat.